These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27152837)

  • 1. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
    Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyester monomers lack ability to bind and activate both androgenic and estrogenic receptors as determined by in vitro and in silico methods.
    Osimitz TG; Welsh WJ; Ai N; Toole C
    Food Chem Toxicol; 2015 Jan; 75():128-38. PubMed ID: 25455886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and virtual screening of androgen receptor antagonists.
    Li J; Gramatica P
    J Chem Inf Model; 2010 May; 50(5):861-74. PubMed ID: 20405856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein.
    Hong H; Branham WS; Ng HW; Moland CL; Dial SL; Fang H; Perkins R; Sheehan D; Tong W
    Toxicol Sci; 2015 Feb; 143(2):333-48. PubMed ID: 25349334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR classification of estrogen receptor binders and pre-screening of potential pleiotropic EDCs.
    Li J; Gramatica P
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):657-69. PubMed ID: 21120754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review.
    Bonefeld-Jørgensen EC; Long M; Hofmeister MV; Vinggaard AM
    Environ Health Perspect; 2007 Dec; 115 Suppl 1(Suppl 1):69-76. PubMed ID: 18174953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key learnings from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 in vitro assays.
    LeBaron MJ; Coady KK; O'Connor JC; Nabb DL; Markell LK; Snajdr S; Sue Marty M
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):23-42. PubMed ID: 24515815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Computational Model for Androgen Receptor Activity.
    Kleinstreuer NC; Ceger P; Watt ED; Martin M; Houck K; Browne P; Thomas RS; Casey WM; Dix DJ; Allen D; Sakamuru S; Xia M; Huang R; Judson R
    Chem Res Toxicol; 2017 Apr; 30(4):946-964. PubMed ID: 27933809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
    Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
    Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity.
    Kjeldsen LS; Ghisari M; Bonefeld-Jørgensen EC
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):453-64. PubMed ID: 23871939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental Effects of the ToxCast™ Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits.
    Boyd WA; Smith MV; Co CA; Pirone JR; Rice JR; Shockley KR; Freedman JH
    Environ Health Perspect; 2016 May; 124(5):586-93. PubMed ID: 26496690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor/androgen receptor transcriptional activation of benzophenone derivatives and integrated approaches to testing and assessment (IATA) for estrogenic effects.
    Lee H; Park J; Ortiz DM; Park K
    Toxicol In Vitro; 2024 Oct; 100():105914. PubMed ID: 39094913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
    Freyberger A; Scholz G
    ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
    Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
    Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens.
    Janesick AS; Dimastrogiovanni G; Vanek L; Boulos C; Chamorro-García R; Tang W; Blumberg B
    Environ Health Perspect; 2016 Aug; 124(8):1214-26. PubMed ID: 26757984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of QSAR models for predicting the binding affinity of endocrine disrupting chemicals to eight fish estrogen receptor.
    He J; Peng T; Yang X; Liu H
    Ecotoxicol Environ Saf; 2018 Feb; 148():211-219. PubMed ID: 29055205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor binding affinity: a QSAR evaluation.
    Todorov M; Mombelli E; Ait-Aissa S; Mekenyan O
    SAR QSAR Environ Res; 2011 Jun; 22(3):265-91. PubMed ID: 21598194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds.
    Fabian E; Gomes C; Birk B; Williford T; Hernandez TR; Haase C; Zbranek R; van Ravenzwaay B; Landsiedel R
    Arch Toxicol; 2019 Feb; 93(2):401-416. PubMed ID: 30552464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.